Nagata, Naoki
Maeda, Hiromichi https://orcid.org/0000-0001-7694-8082
Ishibashi, Keiichiro
Hirata, Keiji
Makiyama, Akitaka
Iwamoto, Shigeyoshi
Takemoto, Hiroyoshi
Imasato, Mitsunobu
Yoshida, Yoichiro
Munemoto, Yoshinori
Tanaka, Chihiro
Morita, Yoshitaka
Hotta, Yoshihiro
Toyofuku, Atsushi
Nagasaka, Takeshi
Morita, Satoshi
Sakamoto, Junichi
Mishima, Hideyuki
Article History
Received: 8 December 2018
Accepted: 11 February 2019
First Online: 24 April 2019
Compliance with ethical standards
:
: NN has received honoraria from Takeda Pharmaceutical Company Ltd. SM has received honoraria (lecture) from Takeda Pharmaceutical Company Ltd., Yakuruto Honsha Ltd., Daiichi-Sankyo Company Ltd. JS has received honoraria (lecture and manuscript fee) from Chugai Pharmaceutical Co. Ltd., Tsumura Co. Ltd., Nihon Kayaku Co. Ltd. and consulting fee from Takeda Pharmaceutical Co. Ltd. outside from this study. Hideyuki Mishima has received speaker honoraria and research funding from Takeda Pharmaceutical Company Ltd., Chugai Pharmaceutical Co. Ltd., Taiho Pharmaceutical Co. Ltd., Daiichi-Sankyo Pharmaceutical Co., and Yakult Honsha Co. Ltd. Other authors declare that they have no conflicts of interest.